MedPath

Dronabinol

These highlights do not include all the information needed to use dronabinol capsules safely and effectively. See full prescribing information for dronabinol capsules. Dronabinol capsules, for oral use, CIII Initial U.S. Approval: 1985

Approved
Approval ID

18cf326f-a5d7-423c-8eff-58057e19cf3e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 16, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dronabinol

PRODUCT DETAILS

NDC Product Code63629-9166
Application NumberNDA018651
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateMarch 25, 2021
Generic NameDronabinol

INGREDIENTS (5)

DRONABINOLActive
Quantity: 2.5 mg in 1 1
Code: 7J8897W37S
Classification: ACTIB
SESAME OILInactive
Code: QX10HYY4QV
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Dronabinol - FDA Approval | MedPath